Major Cancer Meeting Highlights Practice-Changing Cancer Studies

Main Category: Lung Cancer
Also Included In: Conferences;  Breast Cancer;  Prostate / Prostate Cancer
Article Date: 30 Oct 2009 - 5:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

4 news briefings with live webcast previewing studies

The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.

News briefing 1

When: Monday, November 2, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)

What: News briefing with live webcast from ASTRO's 51st Annual Meeting.

Study findings previewed:

• Four months hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patients (late-breaking study).
  
  
• Additional, specialized radiation not necessary for some women after mastectomy.
  
  
• Radiation after surgery reduces chance of melanoma returning.
  
  
• What are the real benefits versus risks of preventative brain radiation for patients with non-small cell lung cancer?

Where: McCormick Place West, Room 176b/c or on the Web at https://astro.webex.com/astro/j.php?ED=117037132&RG=1&UID=0&RT=MiM3

News briefing 2

When: Monday, November 2, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)

What: News briefing with live webcast from ASTRO's 51st Annual Meeting.

Study findings previewed:

• Stereotactic radiotherapy stops lung cancer from growing in frail patients.
  
  
• Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patients.

Where: McCormick Place West, Room 176b/c or on the Web at https://astro.webex.com/astro/j.php?ED=117046102&RG=1&UID=0&RT=MiM3

News briefing 3

When: Tuesday, November 3, at 8:00 a.m. (Central); 9:00 a.m. (Eastern)

What: News briefing with live webcast from ASTRO's 51st Annual Meeting.

Study findings previewed:

• Adding proton therapy "boost" to X-ray radiation therapy reduces prostate cancer recurrences.
  
  
• Proton therapy is well-tolerated in prostate cancer patients.

Where: McCormick Place West, Room 176b/c or on the Web at https://astro.webex.com/astro/j.php?ED=117046192&RG=1&UID=0&RT=MiM3

News briefing 4

When: Tuesday, November 3, at 12:00 p.m. (Central); 1:00 p.m. (Eastern)

What: News briefing with live webcast from ASTRO's 51st Annual Meeting.

Study findings previewed:

• Shorter radiation course stops cancer growth in high-risk prostate cancer patients.
  
  
• Shorter radiation course as effective as standard therapy for prostate cancer recurrence.

Where: McCormick Place West, Room 176b/c, or on the Web at https://astro.webex.com/astro/j.php?ED=117047452&RG=1&UID=0&RT=MiM3

How: To participate in the webcasts, click on the links above to view slides and listen to the audio of the conference live over the Internet.

Source: Beth Bukata
American Society for Radiation Oncology